{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:07:22Z","timestamp":1794344842894,"version":"4.9.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"UBC Cardiology Academic Practice Plan"},{"name":"UBC Cardiology Academic Practice Plan"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Cardiovascular disease accounts for one-third of deaths in patients with chronic obstructive pulmonary disease (COPD). Better control of cardiovascular risk factors in primary care could improve outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To define the prevalence, monitoring, treatment, and control of risk factors in patients with COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Repeated cross-sectional analysis of primary care electronic medical records for all patients with COPD in the Canadian Primary Care Sentinel Surveillance Network from 2013 to 2018 (n\u2009=\u200932,695 in 2018). A control group was matched 1:1 for age, sex, and rural residence (n\u2009=\u200932,638 in 2018). Five risk factors were defined using validated definitions including laboratory results: hypertension, dyslipidemia, diabetes, obesity, and smoking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All risk factors were more common in patients with COPD compared with matched control subjects, including hypertension (52.3% vs. 44.9%), dyslipidemia (62.0% vs. 57.8%), diabetes (25.0% vs. 20.2%), obesity (40.8% vs. 36.8%), and smoking (40.9% vs. 11.4%), respectively. The mean Framingham risk score was 20.6% versus 18.6%, with 53.8% of patients with COPD being high risk (\u2a7e20%). Monitoring of risk factors within the last year in patients with COPD in 2018 was suboptimal: 71.8% hypertension, 39.4% dyslipidemia, 74.5% diabetes, 52.3% obesity. Smoking status was infrequently recorded in the electronic record. In those monitored, guideline recommended targets were achieved in 60.8%, 46.6%, 57.4%, 10.6% and 12.0% for each risk factor. Cardiovascular therapies including angiotensin-converting enzyme inhibitors (69%), statins (69%), and smoking cessation therapies (27%) were underused.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with COPD, major cardiovascular risk factors are common, yet inadequately monitored, undertreated, and poorly controlled. Strategies are needed to improve comprehensive risk factor management proven to reduce cardiovascular morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202104-463oc","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T18:44:22Z","timestamp":1641840262000},"page":"1102-1111","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":25,"title":["Control of Cardiovascular Risk Factors in Patients with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1286-2014","authenticated-orcid":false,"given":"Nathaniel M.","family":"Hawkins","sequence":"first","affiliation":[{"name":"Division of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Peterson","sequence":"additional","affiliation":[{"name":"Centre for Health Services and Policy Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Ezzat","sequence":"additional","affiliation":[{"name":"La Trobe University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Vijh","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"Virani","sequence":"additional","affiliation":[{"name":"Division of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gibb","sequence":"additional","affiliation":[{"name":"Centre for Health Services and Policy Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. B. John","family":"Mancini","sequence":"additional","affiliation":[{"name":"Division of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina T.","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre for Health Services and Policy Research"},{"name":"School of Nursing, University of British Columbia, Vancouver, British Columbia, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2026012203330467100_bib1","author":"Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease"},{"key":"2026012203330467100_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"2026012203330467100_bib3","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"2026012203330467100_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/thoraxjnl-2014-205956","article-title":"Mortality trends in women and men with COPD in Ontario, Canada, 1996-2012","volume":"70","author":"Gershon","year":"2015","journal-title":"Thorax"},{"key":"2026012203330467100_bib5","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"2026012203330467100_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0954-6111(98)90310-9","article-title":"Survival experience of the population needing hospital treatment for asthma or COPD at age 50-54 years","volume":"92","author":"Keistinen","year":"1998","journal-title":"Respir Med"},{"key":"2026012203330467100_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000196687","article-title":"Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital","volume":"64","author":"Vilkman","year":"1997","journal-title":"Respiration"},{"key":"2026012203330467100_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/thx.2006.072348","article-title":"Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee","volume":"62","author":"McGarvey","year":"2007","journal-title":"Thorax"},{"key":"2026012203330467100_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026012203330467100_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.rmed.2014.10.015","article-title":"The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNHANES 2010-2012","volume":"109","author":"Jo","year":"2015","journal-title":"Respir Med"},{"key":"2026012203330467100_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1164\/rccm.201209-1665OC","article-title":"Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease","volume":"187","author":"Vanfleteren","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203330467100_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1183\/09031936.00024709","article-title":"Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study","volume":"35","author":"Lam","year":"2010","journal-title":"Eur Respir J"},{"key":"2026012203330467100_bib13","doi-asserted-by":"crossref","first-page":"e98013","DOI":"10.1371\/journal.pone.0098013","article-title":"Prevalence of metabolic syndrome in COPD patients and its consequences","volume":"9","author":"Breyer","year":"2014","journal-title":"PLoS One"},{"key":"2026012203330467100_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3122\/jabfm.2013.02.120183","article-title":"Validation of the diagnostic algorithms for 5 chronic conditions in the Canadian Primary Care Sentinel Surveillance Network (CPCSSN): a Kingston Practice-based Research Network (PBRN) report","volume":"26","author":"Kadhim-Saleh","year":"2013","journal-title":"J Am Board Fam Med"},{"key":"2026012203330467100_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1370\/afm.1644","article-title":"Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records","volume":"12","author":"Williamson","year":"2014","journal-title":"Ann Fam Med"},{"key":"2026012203330467100_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10916-017-0694-7","article-title":"Identification of dyslipidemic patients attending primary care clinics using electronic medical record (EMR) data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) database","volume":"41","author":"Aref-Eshghi","year":"2017","journal-title":"J Med Syst"},{"key":"2026012203330467100_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"2026012203330467100_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3122\/jabfm.2009.04.090081","article-title":"Building a pan-Canadian primary care sentinel surveillance network: initial development and moving forward","volume":"22","author":"Birtwhistle","year":"2009","journal-title":"J Am Board Fam Med"},{"key":"2026012203330467100_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"2026012203330467100_bib20","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.17269\/cjph.106.4508","article-title":"Adult obesity prevalence in primary care users: an exploration using Canadian Primary Care Sentinel Surveillance Network (CPCSSN) data","volume":"106","author":"Rigobon","year":"2015","journal-title":"Can J Public Health"},{"key":"2026012203330467100_bib21","first-page":"i","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","author":"World Health Organization","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2026012203330467100_bib22","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.9778\/cmajo.20140038","article-title":"Prevalence and management of hypertension in primary care practices with electronic medical records: a report from the Canadian Primary Care Sentinel Surveillance Network","volume":"3","author":"Godwin","year":"2015","journal-title":"CMAJ Open"},{"key":"2026012203330467100_bib23","first-page":"506","article-title":"Hypertension Canada\u2019s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"key":"2026012203330467100_bib24","first-page":"1263","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"2026012203330467100_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12944-015-0056-8","article-title":"Low density lipoprotein cholesterol control status among Canadians at risk for cardiovascular disease: findings from the Canadian Primary Care Sentinel Surveillance Network Database","volume":"14","author":"Aref-Eshghi","year":"2015","journal-title":"Lipids Health Dis"},{"key":"2026012203330467100_bib26","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jcjd.2017.10.030","article-title":"Targets for Glycemic Control","volume":"42","author":"Diabetes Canada Clinical Practice Guidelines Expert Committee","year":"2018","journal-title":"Can J Diabetes"},{"key":"2026012203330467100_bib27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/COPD.S49621","article-title":"Epidemiology and clinical impact of major comorbidities in patients with COPD","volume":"9","author":"Smith","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203330467100_bib28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2026012203330467100_bib29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.amjcard.2017.07.032","article-title":"Relation of chronic obstructive pulmonary disease to cardiovascular disease in the general population","volume":"120","author":"Song","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026012203330467100_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-11-50","article-title":"Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies","volume":"11","author":"R\u00fcckert","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"2026012203330467100_bib31","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/CIRCULATIONAHA.118.039100","article-title":"Cardiovascular risk and risk factor management in type 2 diabetes mellitus","volume":"139","author":"Wright","year":"2019","journal-title":"Circulation"},{"key":"2026012203330467100_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/dc08-1918","article-title":"Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk equations in estimating cardiovascular disease in the EPIC- Norfolk Cohort","volume":"32","author":"Simmons","year":"2009","journal-title":"Diabetes Care"},{"key":"2026012203330467100_bib33","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"2026012203330467100_bib34","first-page":"393","article-title":"Cardiovascular risk factor management performance in Canada and the United States: a systematic review","volume":"33","author":"Alabousi","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026012203330467100_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0035-1555610","article-title":"Smoking cessation in chronic obstructive pulmonary disease","volume":"36","author":"Tashkin","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012203330467100_bib36","doi-asserted-by":"crossref","first-page":"e00114","DOI":"10.1002\/edm2.114","article-title":"Cardiovascular risk factor control in British adults with diabetes mellitus: retrospective cohort study","volume":"3","author":"Collins","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"2026012203330467100_bib37","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2018.11.067","article-title":"Lifestyle, glycosylated hemoglobin A1c, and Survival among patients with stable ischemic heart disease and diabetes","volume":"73","author":"Mancini","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012203330467100_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012203330467100_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"2026012203330467100_bib40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"Group","year":"1998","journal-title":"BMJ"},{"key":"2026012203330467100_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"2026012203330467100_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2458-12-329","article-title":"The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from The Health Improvement Network (THIN) database","volume":"12","author":"Taggar","year":"2012","journal-title":"BMC Public Health"},{"key":"2026012203330467100_bib43","doi-asserted-by":"crossref","first-page":"E442","DOI":"10.1503\/cmaj.190848","article-title":"Calibration and discrimination of the Framingham risk score and the pooled cohort equations","volume":"192","author":"Ko","year":"2020","journal-title":"CMAJ"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/7\/1102\/66330880\/annalsats_19_7_1102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/7\/1102\/66330880\/annalsats_19_7_1102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:36:23Z","timestamp":1769070983000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/19\/7\/1102\/8417956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,1]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202104-463oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7]]},"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"2021-04-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}